Healthcare

By

Bruce Kamich

 | Sep 15, 2017 | 1:45 PM EDT
The charts don't look positive for drug company Eli Lilly.
By

James "Rev Shark" DePorre

 | Sep 14, 2017 | 10:30 AM EDT
The indices may need a rest, but stock-pickers have an edge.
By

Bruce Kamich

 | Sep 13, 2017 | 3:44 PM EDT
The path of least resistance for LLY is lower.
By

Bruce Kamich

 | Sep 13, 2017 | 11:11 AM EDT
There are some bearish signs developing for the stock.
By

Bruce Kamich

 | Sep 13, 2017 | 10:15 AM EDT
But longs should consider raising sell stops to $79 from $68.
By

Bruce Kamich

 | Sep 12, 2017 | 11:34 AM EDT
A retest of MYL's recent low is an important area.
By

Bruce Kamich

 | Sep 12, 2017 | 9:56 AM EDT
Damage on TEVA's charts is significant.
RMPIA
By

Bret Jensen

 | Sep 8, 2017 | 2:30 PM EDT
T2 Biosystems and Synergy Pharmaceuticals offer promising prospects at reasonable prices.
By

Bruce Kamich

 | Sep 8, 2017 | 11:01 AM EDT
Look for NTLA to go higher from here.
By

Bruce Kamich

 | Sep 8, 2017 | 10:09 AM EDT
Shares of this biotech look ready for further strong gains.
As far as TSLA is concerned, I still have a higher target above the market at the 409 area...
The TLT setup discussed in my last commentary is a bust. Key support was violated and it v...
BBY is getting smoked this mornings(weak forecast).  The stock is off 8% after openin...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.